IHC confirmed the diagnosis of DLBCL (germinal center B-cell subtype), as the tumor cells were positive for Oct-2, CD20, PAX5, BCL-6, and CD10 (Figures 6-9) and negative for CD38 (Figure 10), CD138, MUM1, and CD30. This evidence concerns the gene CD38 and diffuse large B-cell lymphoma.